astemizole has been researched along with Macular Edema in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effects of astemizole, an antihistamine, versus placebo on the 1-year course of diabetic macular edema (DME) and to illustrate use of a modified ETDRS system for grading areas of retinal thickening and hard exudates that may be useful in clinical trials of treatments for this disorder." | 9.12 | An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial. ( Blankenship, GW; Brod, RD; Davis, MD; Gardner, TW; Hubbard, L; Kunselman, A; Larsen, ML; Lund-Andersen, H; Parving, HH; Post-Hansen, H; Quillen, DA; Reimers, J; Sander, B; Tenhave, T; Wilmarth, MH, 2006) |
| "To compare the effects of astemizole, an antihistamine, versus placebo on the 1-year course of diabetic macular edema (DME) and to illustrate use of a modified ETDRS system for grading areas of retinal thickening and hard exudates that may be useful in clinical trials of treatments for this disorder." | 5.12 | An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial. ( Blankenship, GW; Brod, RD; Davis, MD; Gardner, TW; Hubbard, L; Kunselman, A; Larsen, ML; Lund-Andersen, H; Parving, HH; Post-Hansen, H; Quillen, DA; Reimers, J; Sander, B; Tenhave, T; Wilmarth, MH, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardner, TW | 1 |
| Sander, B | 1 |
| Larsen, ML | 1 |
| Kunselman, A | 1 |
| Tenhave, T | 1 |
| Lund-Andersen, H | 1 |
| Reimers, J | 1 |
| Hubbard, L | 1 |
| Blankenship, GW | 1 |
| Quillen, DA | 1 |
| Brod, RD | 1 |
| Wilmarth, MH | 1 |
| Post-Hansen, H | 1 |
| Parving, HH | 1 |
| Davis, MD | 1 |
1 trial available for astemizole and Macular Edema
| Article | Year |
|---|---|
An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial.
Topics: Adult; Astemizole; Blood-Retinal Barrier; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmologi | 2006 |